BridgeMD
The effect of cabergoline in infertile women on peritoneal endometriosis related dysmenorrhea, chronic pelvic pain and fertility
EU CTIS ID: 2022-500792-31-00
What this study is testing
to evaluate the effectiveness of cabergoline on endometriosis associated pain symptoms among infertile patients with mild or moderate endometriosis.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- - Females - Age 20 – 37 year - Mild or moderate endometriosis either diagnosed by surgery or ultrasound or strong clinical suspicion of peritoneal endometriosis based on NICE Guidelines - Endometriosis related pain NRS > 3 (dysmenorrhea) - Primary or secondary infertility for 1 year or more - Cause of infertility: mild or moderate endometriosis, unknown ‘ - Regular ovulatory cycles
You likely can't join if
- - Body mass index more than 35 kg/m2 or less than 18 kg/m2 - Severe endometriosis defined as o > 4 cm unilateral endometrioma or bilateral endometriomas o Adhesions above the level of sacrouterine ligaments demonstrated by absent sliding sign in ultrasound examination or detected surgically o Deep invasive endometriosis of bowel - Hormonal suppression of endometriosis or hormonal contraception within 6 mo - Other diagnosed cause of infertility o Ovulatory dysfunction o Tubal factor (Tubal occlusion, hydrosalpinx, tubal sterilization) o Uterine factor (Submucous myoma, intramural myoma > 4 cm, Uterine malformation apart from Uterus arcuatus) o Male factor o Social infertility - Indication for IVF-treatment - Hyperprolactinemia, macroprolactinemia excluded - Unbalanced hypothyreoidism - Cardiac disorders - Pleural, pericardiac or retroperinoteal fibrosis - Liver dysfunction - Clinical depression or other phychiatric disorder - Previous malignancy - Allergy for cabergoline - Insufficient skills in Finnish, Swedish or English language
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.